Position in QGEN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,105,239
-$144,067,427 QoQ
Shares Held
28,267
-99.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#159
of 332 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Boston Partners holds $3,083,291,652 across 9 Diagnostics & Research names. QGEN ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
4,744,473 | $1,005,591,051 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
4,466,016 | $862,923,609 | |
| 3 | LH |
Labcorp Holdings Inc.
|
3,051,690 | $854,473,200 | |
| 4 | ICLR |
Icon PLC
|
1,620,730 | $281,537,007 | |
| 5 | CDNA |
CareDx, Inc.
|
1,937,601 | $55,221,628 | |
| 6 | A |
Agilent Technologies, Inc.
|
122,187 | $16,230,099 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
10,819 | $5,424,213 | |
| 8 | QGEN |
Qiagen N.V.
This page
|
28,267 | $1,105,239 |
All Filings in QGEN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,105,239 | 28,267 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $145,172,666 | 3,625,691 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $178,981,318 | 3,980,016 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $179,419,151 | 4,015,648 | Shares | Other | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||